Activity of ceftibuten, cefaclor, azithromycin, clarithromycin, erythromycin and telithromycin against Streptococcus pyogenes clinical isolates with different genotypes and phenotypes

Chemotherapy

Volumn 51, Issue 5, 2005, Pages 268-271

  Drago, Lorenzo ^b   Ripa, Sandro ^a   Zampaloni, Claudia ^a   De Vecchi, Elena ^b   Vitali, Luca A ^a   Petrelli, Dezemona ^a   Prenna, Manuela ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Cephalosporins; M typing; Macrolides; Streptococcus pyogenes; Telithromycin

Indexed keywords

AZITHROMYCIN; CEFACLOR; CEFTIBUTEN; CEPHALOSPORIN; CLARITHROMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; DILUTION; GENOTYPE; HUMAN; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 23944520337     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087254     Document Type: Article

References (20)

1. Elsayed S, Laupland KB: Emerging gram-positive bacterial infections. Clin Lab Med 2004;24:587-603.
2. Mulla ZD: Invasive group A streptococcal disease and intensive care unit admissions. Intensive Care Med 2002;28:1822-1824.
3. Hedrick J: Acute bacterial skin infections in pediatric medicine: Current issues in presentation and treatment. Pediatr Drugs 2003;5(suppl 1):35-46.
4. Pichichero ME, Cohen R: Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997;16:680-695.
5. Scholz H: Streptococcal-A tonsillopharyngitis: A 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. Results depending on the children's age. Chemotherapy 2004;50:51-54.
6. Owens RC, Nightingale CH: Ceftibuten: An overview. Pharmacotherapy 1997;17:707-720.
7. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, Seppala H: Finnish Study group for Antimicrobial Resistance (FiRe Network): Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland. Clin Infect Dis 2004;38:1251-1256.
8. Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M: Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: Results from the PROTEKT surveillance study (1999-2000). Chemotherapy 2004;50:143-151.
9. Seppälä H, Nissinen A, Yu Q, Huovinen P: Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993;32:885-891.
10. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppälä H: Nomenclature for macrolide and macrolide-lincosamide - streptogramin B resistance determinants. Antimicrob Agents Chemother 1999;43:2823-2830.
11. Seppälä H, Skurnik M, Soini H, Roberts MC, Huovinen P: A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998;42:257-262.
12. Giovanetti E, Montanari MP, Mingoia M, Varaldo PE: Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 1999;43:1935-1940.
13. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, ed 6 (M07-A6). NCCLS, Villanova, 2003.
14. Buxbaum A, Forsthuber S, Graninger W, Georgopoulos A: Comparative activity of telithromycin against typical community acquired-respiratory pathogens. J Antimicrob Chemother 2003;52, 371-374.
15. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L: Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996;40:2562-2566.
16. Zampaloni C, Cappelletti P, Prenna M, Vitali LA, Ripa S: emm gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol 2003;41:1307-1310.
17. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA: Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 1996;2:867-879.
18. Vitali LA, Zampaloni C, Prenna M, Ripa S: PCR M Typing: A new method for rapid typing of group A streptococci. J Clin Microbiol 2002;40:679-681.
19. Gehanno P, Sultan E, Passot V, Nabet P, danon J, Romanet P, Attal P: Telithromycin (HMR 3647) achieves high and sustained concentrations in tonsils of patients undergoing tonsillectomy. Int J Antimicrob Agents 2003;21:441-445.
20. Facklam R, Beall B, Efstration A, Fischetti V, Johnson D, Kaplan E, Kriz P, Lovgren M, Martin D, Schwartz B, Totolian A, Bessen D, Hollingshead S, Rubin F, Scott J, Tyrrel G: emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999;5:247-253.